North America contributes the largest share of the Primary Sclerosing Cholangitis Market
The global Primary Sclerosing Cholangitis Market is estimated to be valued at US$ 3,604.7 Mn in 2022 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview Primary sclerosing cholangitis (PSC) is a chronic, progressive liver disease characterized … Read more